Cellectis Announces Shareholder Figures and Contact Details
Cellectis, a leading genome engineering company, has announced its latest shareholder figures and contact details for media and investor relations as of September 30, 2025.
The company's total number of voting rights stands at 89,413,272. Additionally, the total number of shares in the capital amounts to 100,325,229. For any media inquiries, Pascalyne Wilson, Director of Communications, and Patricia Sosa Navarro, Chief of Staff to the CEO, are available. They can be reached at [email protected] and +33 7 76 99 14 33, and +33 7 76 77 46 93 respectively. For investor relations, Arthur Stril, Chief Financial Officer & Chief Business Officer, is the point of contact. He can be reached at [email protected].
Cellectis' shareholder figures reflect the company's growth and commitment to its investors. The updated contact details ensure seamless communication with media and investors.
